Lux Amber, Corp. (LXAM) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
145 ROSE LANE, SUITE 102 FRISCO, TX 75036 |
| State of Incorp. | NV |
| Fiscal Year End | April 30 |
| Industry (SIC) | 286 - Industrial Organic Chemicals (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 1/31/2022 MRQ | 4/30/2021 | 4/30/2019 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 14 | ||||
| Cash and cash equivalent | 14 | ||||
| Receivables | 113 | ||||
| Inventory, net of allowances, customer advances and progress billings | 137 | ||||
| Inventory | 137 | ||||
| Other current assets | 6 | ||||
| Other undisclosed current assets | 2 | ||||
| Total current assets: | 258 | 14 | |||
| Noncurrent Assets | |||||
| Operating lease, right-of-use asset | 273 | ✕ | |||
| Property, plant and equipment | 513 | ||||
| Intangible assets, net (including goodwill) | 2,310 | 3 | |||
| Goodwill | 2,295 | ||||
| Intangible assets, net (excluding goodwill) | 15 | 3 | |||
| Other undisclosed noncurrent assets | (3) | ||||
| Total noncurrent assets: | 3,095 | ||||
| TOTAL ASSETS: | 3,353 | 14 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,756 | 21 | |||
| Interest and dividends payable | 1 | ||||
| Accounts payable | 555 | 16 | |||
| Accrued liabilities | 1,202 | 4 | |||
| Debt | 113 | ||||
| Due to related parties | 209 | 10 | |||
| Other undisclosed current liabilities | 172 | ||||
| Total current liabilities: | 2,250 | 30 | |||
| Noncurrent Liabilities | |||||
| Long-term debt and lease obligation | 113 | 15 | |||
| Long-term debt, excluding current maturities | 15 | 15 | |||
| Operating lease, liability | 99 | ✕ | |||
| Other undisclosed noncurrent liabilities | 6 | ||||
| Total noncurrent liabilities: | 218 | 15 | |||
| Total liabilities: | 2,469 | 45 | |||
| Equity | |||||
| Equity, attributable to parent | 885 | (31) | |||
| Common stock | 3 | 0 | |||
| Additional paid in capital | 15,750 | 23 | |||
| Accumulated deficit | (14,869) | (54) | |||
| Total equity: | 885 | (31) | |||
| TOTAL LIABILITIES AND EQUITY: | 3,353 | 14 | |||
Income Statement (P&L) ($ in thousands)
| 1/31/2022 TTM | 4/30/2021 | 4/30/2019 | ||
|---|---|---|---|---|
| Revenues | 999 | |||
| Cost of revenue (Cost of Product and Service Sold) | (684) | |||
| Gross profit: | 315 | |||
| Operating expenses | (2,341) | (48) | ||
| Other operating expense, net (Other Expenses) | (29) | |||
| Operating loss: | (2,055) | (48) | ||
| Nonoperating income | 42 | |||
| Other nonoperating income | 109 | |||
| Interest and debt expense | 33 | (1) | ||
| Loss from continuing operations: | (1,980) | (49) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (1,980) | (49) | |
| Other undisclosed net loss | (4) | |||
| Net loss available to common stockholders, diluted: | (1,984) | (49) | ||
Comprehensive Income ($ in thousands)
| 1/31/2022 TTM | 4/30/2021 | 4/30/2019 | ||
|---|---|---|---|---|
| Net loss: | (1,984) | (49) | ||
| Comprehensive loss, net of tax, attributable to parent: | (1,984) | (49) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.